feed,title,long_url,short_url
SeekingAlpha,Arrowhead Pharmaceuticals: Olpasiran's Impressive Phase 2 Data,https://seekingalpha.com/article/4554599,
SeekingAlpha,"Palantir: -11.48% After Earnings, And My Investment Thesis Is Changing",https://seekingalpha.com/article/4554710,
